Author:Teigan Sutton

Expanded Access Programs

Blogs/Articles, Rare diseases

EMA orphan drug designation
rare and orphan diseases

Blogs/Articles, Rare diseases

The increasing importance of real-world data for the EMA
patient support program in europe

Thought Leadership, Rare diseases

Navigating the transition from open label extensions to early access programs
Boys playing football

Thought Leadership, Rare diseases

Leveraging Early Access Programs and Real-World Data for commercial success
orphan drugs supply chain management

Blogs/Articles, Rare diseases

Planning your EU orphan drug stock management with Sciensus
packaging and labelling

Blogs/Articles, Rare diseases

Packaging and label compliance in Europe: Successfully navigating regulations with Sciensus 

Thought Leadership, Rare diseases

Sciensus webinar with Fierce Biotech: Unlocking the European orphan drug market